TGM2 and autoimmune disease: The expression of autoimmune phenomena (8, 9), first of all the presence in the serum of anti-tissue transglutaminase 2 (anti-TG2) antibodies (10), and the strict association with autoimmune disorders suggested ESPGHAN to define CD as a systemic autoimmune disease (1).